Wells Fargo’s Treace Medical Concepts TMCI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$157K Buy
26,646
+591
+2% +$3.48K ﹤0.01% 4519
2025
Q1
$219K Buy
26,055
+1,259
+5% +$10.6K ﹤0.01% 4204
2024
Q4
$184K Buy
24,796
+7,769
+46% +$57.8K ﹤0.01% 4359
2024
Q3
$98.8K Sell
17,027
-2,188
-11% -$12.7K ﹤0.01% 4635
2024
Q2
$128K Buy
19,215
+3,591
+23% +$23.9K ﹤0.01% 4439
2024
Q1
$204K Buy
15,624
+2,959
+23% +$38.6K ﹤0.01% 4100
2023
Q4
$161K Buy
12,665
+2,119
+20% +$27K ﹤0.01% 4216
2023
Q3
$138K Sell
10,546
-10,545
-50% -$138K ﹤0.01% 4261
2023
Q2
$540K Buy
21,091
+11,011
+109% +$282K ﹤0.01% 3691
2023
Q1
$254K Buy
10,080
+9,022
+853% +$227K ﹤0.01% 4040
2022
Q4
$24.3K Sell
1,058
-16,107
-94% -$370K ﹤0.01% 4866
2022
Q3
$379K Buy
17,165
+16,195
+1,670% +$358K ﹤0.01% 3617
2022
Q2
$14K Sell
970
-27,145
-97% -$392K ﹤0.01% 5328
2022
Q1
$531K Sell
28,115
-6,523
-19% -$123K ﹤0.01% 4094
2021
Q4
$646K Sell
34,638
-78,689
-69% -$1.47M ﹤0.01% 4177
2021
Q3
$3.05M Buy
113,327
+39,814
+54% +$1.07M ﹤0.01% 3143
2021
Q2
$2.3M Buy
+73,513
New +$2.3M ﹤0.01% 3397